Harbor MedTech, Inc.
PrivateLast Round
Series B
Extension
Sep 20, 2017
Total Funding Raised
$10.2M
Company Overview
Harbor MedTech, Inc. operates in Healthcare & Life Sciences and is based in Irvine, California. Its latest recorded funding round was a Series B Extension round in September 2017.
Harbor MedTech, Inc. is a commercial-stage regenerative medicine company that provides advanced orthopedic soft tissue repair solutions using its patented BriDGE® technology to transform collagen into a bio-friendly, stabilized collagen matrix.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Harbor MedTech, Inc. Comparables
Compare Harbor MedTech, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tides Medical | 83% | |
| Organogenesis Holdings Inc. | 81% | |
| Tissue Regenix Group plc | 79% |
For institutional investors. Book with your work email.
Harbor MedTech, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Sep 20, 2017 | ||||
| Series B | Oct 7, 2016 | ||||
| Seed | Apr 27, 2013 |
For institutional investors. Book with your work email.
Harbor MedTech, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Arsenal Capital Partners | Series B, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 20, 2017
$3M round led by Arsenal Capital Partners.
- Oct 7, 2016
$5M round led by Arsenal Capital Partners.
For institutional investors. Book with your work email.
Harbor MedTech, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Harbor MedTech, Inc.'s valuation, stock price, and market status.
Is Harbor MedTech, Inc. a public or private company?
Harbor MedTech, Inc. is a private company.
What is the current stock price of Harbor MedTech, Inc.?
Harbor MedTech, Inc. is a private company, so its shares have no public market price. Caplight tracks Harbor MedTech, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Harbor MedTech, Inc. worth (valuation)?
Valuation information for Harbor MedTech, Inc. is not publicly available.
Can I buy Harbor MedTech, Inc. stock?
Harbor MedTech, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Harbor MedTech, Inc.'s last funding round?
Harbor MedTech, Inc.'s most recent funding round was Series B Extension on September 20, 2017.
Who are the main investors in Harbor MedTech, Inc.?
Key investors in Harbor MedTech, Inc. include Arsenal Capital Partners.
Will Harbor MedTech, Inc. IPO soon?
No public IPO plans have been announced for Harbor MedTech, Inc..
How can I track Harbor MedTech, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Harbor MedTech, Inc.'s shares on secondary markets.